Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study
about
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.A rule-based prognostic model for type 1 diabetes by identifying and synthesizing baseline profile patterns.Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesThe metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.Prognostic Classification Factors Associated With Development of Multiple Autoantibodies, Dysglycemia, and Type 1 Diabetes-A Recursive Partitioning Analysis.The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.Reduction of circulating neutrophils precedes and accompanies type 1 diabetesThe prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsThe relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.Trials in the prevention of type 1 diabetes: current and futureIncreasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.Staging the progression to type 1 diabetes with prediagnostic markersDifferentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes.A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
P2860
Q27334960-74650E21-D480-4F0F-B519-83C33EB913F6Q27334999-F4EC4484-A146-43A7-B64B-2522E0A8EE87Q27346599-14E322E0-00EC-4221-9523-735F32CAC895Q30574604-7FBBDD40-83C3-4BF9-8C8B-BFF2AB26E51EQ33753191-16017124-2008-422E-BE57-E133AEC22777Q34318993-CE53DE6C-17AC-4290-A719-804AF16C32C1Q35674747-306E0B1E-24BF-4463-9C51-E30549692D0CQ35976503-32427933-4812-4468-BF9D-A1EFD05E1B0FQ35976782-E60C4526-FDD0-4BFF-B3F7-7DDBFACB2EC8Q36025138-5853385D-4EEC-4AFD-AE07-A9AFD300DBADQ36047238-17BB1410-F8F0-4C29-B630-C9A9C82E8566Q36867514-B936259F-5F1B-43B0-AF18-96EF6D61F91DQ37106456-B5174768-B867-4B87-B07A-01793D04E6A0Q37368421-94864A89-AFC0-4BA2-A4E2-344F463ADE0DQ38237031-0507CDB9-D4C8-4A49-ABA4-9326B6D27C5EQ38679602-D0F9CF0B-1286-4265-AF7B-049F22652673Q38846782-D5CC27C9-7EAC-4CA2-B711-52D7CCD4F864Q39040207-A34CA820-8DAA-43B6-A1EF-FD4447F5DFA1Q45818945-A4A7F68F-1147-4993-A71A-58347FECBD59Q57133051-E6EBAE86-B98A-4539-A2BD-BEC3BE75025E
P2860
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@ast
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@en
type
label
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@ast
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@en
prefLabel
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@ast
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@en
P2093
P2860
P356
P1433
P1476
Validation of the Diabetes Pre ...... TrialNet Natural History Study
@en
P2093
Carla J Greenbaum
Catherine Cowie
Craig A Beam
David C Boulware
David Cuthbertson
Jay M Sosenko
Jay S Skyler
Jeffrey Mahon
Jeffrey P Krischer
Jerry P Palmer
P2860
P304
P356
10.2337/DC11-0641
P407
P577
2011-06-16T00:00:00Z